Australian medical practices are entering a period where several pressures arrive at once. Costs and interest rates are rising, patient volumes are flattening in key segments, government is looking for savings, and well-capitalised consolidators are reshaping ownership across primary care, specialist practice and diagnostics. Each of these trends is manageable on its own. Together, they change the economics of running an independent practice. This note sets out what is happening, what it means, and the strategic options available to practice owners.
1. The macro backdrop: higher costs, higher rates, slower growth
The global environment has become more volatile. Conflict in the Middle East, a shifting balance of economic power between the US and China, and disrupted trade routes have fed through to energy and commodity prices. The RBA expected the rise in fuel and raw material costs to push inflation higher over the following year, and that is what has happened.
The policy response has been firm. On 29 September the RBA lifted the cash rate by 25 basis points to 4.60%, its fourth increase this year. That is the highest cash rate in 15 years, with inflation currently at 3.5%, and the Board has signalled it is prepared to raise rates further if required.
Meanwhile growth is soft. GDP grew 0.4% in the June quarter and 2.1% over the year, but productivity was flat in the quarter and 0.2% lower over the year, and GDP per capita was flat.
For practices, this means wages, rent, consumables, equipment and insurance are all rising. Debt costs more. And patients facing higher mortgage payments are more cautious about elective care and out-of-pocket costs.
2. What our data shows: the volume tailwind has faded
Our monthly tracking points to the same conclusion from the demand side:
- Private surgery has plateaued. The Practice Alliance Private Surgery Index is growing at about 2% a year, just over half its long-run pace.
- Specialist consultations, the main path into elective surgery, have been falling for about 18 months.
- GP attendances have returned to growth, though from a level well below pre-COVID.
- Consultant physician attendances continue to grow at around 4% a year, driven by ageing and chronic disease.
In short, the post-COVID catch-up is over. Growth in procedural specialties will have to come from margin and market share, not from a rising tide.
3. The policy squeeze: government looking for savings
The 2026–27 Budget added a further headwind for private surgery. The private health insurance rebate will be cut by four percentage points for people aged 65 to 69, and by eight percentage points for those aged 70 and over. The change takes effect from 1 April 2027.
The government's own estimate is modest: it expects 44,000 older Australians to drop their cover. The bigger risk is downgrading. Private Healthcare Australia warns that many more older people may move to lower levels of cover, increasing the chance they won't be adequately insured for procedures they later need, with regional Australia likely to be hit hardest.
This matters most for specialties whose patients skew older, such as ophthalmology, cardiology, orthopaedics and urology. Cataract surgery, for example, is excluded from many lower-tier hospital policies. A shift from comprehensive to basic cover could push some procedures towards the public system or self-funded pathways, and increase price sensitivity for the rest.
4. The consolidation wave
Consolidation is no longer limited to diagnostics. It now spans the whole patient journey.
- General practice. Insurers have become major GP owners. Medibank owns or has stakes in more than 160 GP clinics, and Bupa has agreed to acquire Partnered Health Group from Quadrant Private Equity, subject to approval. Insurers now own around 15% of group general practices nationally.
- Ophthalmology. Large networks are building scale through acquisition. SMS Healthcare, backed by private equity group Alceon, has grown through a series of acquisitions including LASERSIGHT, Medownick Laser Clinic and KindSIGHT Eye Specialists, followed by Sydney Eye Clinic and Southern Ophthalmology. Vision Eye Institute is the largest private ophthalmic provider in Australia, with clinics and day surgeries across four states.
- Radiology. Permira is selling I-MED, Australia's largest radiology provider, to Hong Kong-based Jardine Matheson for US$2.4 billion, a sign that global strategic capital now sees Australian healthcare platforms as long-term assets.
- Pathology has long been dominated by a few large listed operators, and cardiology and other procedure-heavy specialties are attracting growing consolidator interest, following a pattern already well advanced in the US.
The concern within the profession is twofold. Insurer ownership of GP clinics creates the opportunity to steer patients to contracted specialists or insurer-owned hospitals. And larger operators can offer doctors better pay, which independent clinics may struggle to match.
5. What this means for medical practices
Put together, these trends create five practical consequences:
- Margins are under pressure from both sides. Costs are rising faster than fees and rebates, while volume growth no longer covers the gap.
- Referral flows are less secure. As GP clinics consolidate under insurers and corporate groups, independent specialists face the risk that referrals follow ownership.
- The fight for talent intensifies. Consolidators can offer equity, career paths and back-office support that most independents cannot. This affects doctors, nurses and practice managers alike.
- Scale matters more. Investment in technology, cybersecurity, AI-enabled administration and compliance is increasingly unaffordable for a single practice to carry alone.
- Valuations are being repriced. Higher interest rates raise the cost of capital and put pressure on acquisition multiples. Owners planning an exit in the next three to five years may face a less generous market than the one their peers enjoyed in 2021–24.
6. Strategic alternatives
There is no single right answer. The best path depends on a practice's scale, specialty, ownership and the principals' personal horizons. We see five broad options:
- Stay independent and sharpen operations. This suits practices with strong referral bases, a stable doctor group and a long ownership horizon. It requires discipline on utilisation, billing, case mix and cost, plus deliberate investment in referrer relationships and patient experience. The risk is falling behind on technology and talent.
- Collaborate without selling. Independent practices can share services such as billing, procurement, IT, cybersecurity, recruitment and compliance, gaining scale benefits while keeping clinical and ownership control. This model is common in the US, where management services organisations support independent groups, and it is gaining ground here.
- Take on a minority partner. Selling a minority stake to a strategically aligned partner can fund growth, de-risk the principals and bring management capability, while keeping doctors in control. It also creates a clearer path to a future exit.
- Sell to a consolidator. For principals nearing retirement or facing succession gaps, a full or majority sale can make sense. Timing matters, and so does diligence on the buyer's referral model, culture and treatment of clinicians after the deal. Earn-outs and rollover equity should be scrutinised carefully.
- Become a consolidator. Well-run practices with management depth can grow by acquiring smaller neighbours or retiring principals' practices. Higher rates make debt-funded growth harder, but they also soften seller expectations, which can create opportunity for disciplined buyers.
What pays off regardless of path
Across all five options, a few moves pay off regardless:
- Lean into the growth segments. Physician-led chronic disease care is growing steadily, and practices that can support it, including through nurse-led and allied health models, are building on demand rather than fighting for share.
- Protect referral pathways. Map where your referrals come from, how concentrated they are, and which referrers sit inside consolidating groups.
- Stress-test the business. Model FY27-28 on flat volume, cost inflation of around 4% and the April 2027 insurance changes. If the numbers don't work under those assumptions, the strategy needs to change now rather than later.
Conclusion
The past few years rewarded growth. The next few will reward resilience, scale and clear strategy. Practices that act early, whether by sharpening operations, partnering or planning an exit on their own terms, will be in a far stronger position than those that wait for conditions to improve.
Next steps
Connect with us to learn how Practice Alliance can help your practice.